MUMBAI: GenAI-driven healthcare Insurance fraud and risk management company Consint.AI has raised Rs 5 crore in a seed round led by Equanimity Ventures and Seafund. The capital raised will be deployed to scale operations through expanded sales outreach and accelerate the development of the genAI feature suite for the health AI platform.
This includes enhancing fraud detection, optimising claims processing, and delivering personalised clinical care. Funding raised in the current round will also support team expansion, infrastructure upgrades, and R&D efforts to help it grow in the health tech solutions market.
Says Seafund managing partner Manoj Agarwal: “Our focus on emerging tech like GenAI, deep tech, IoT and sustainability has been the guiding force when it comes to backing unique and innovative startups. Consint.AI’s laser sharp focus on solving the problem of healthcare insurance claims processing and fraud detection improving performance of insurance and healthcare institutions is a multi-billion dollar problem to solve and we believe that we have the necessary expertise and network to help the company grow and reach its ambitions.”
Adds Consint founder & CEO Ashish Chaturvedi: "This current market traction and milestones highlight the transformative potential of generative AI in reshaping healthcare as we know it. At Consint.AI, we are pioneering genAI-driven platforms like CIPHR.ai and Risk.ai to solve complex challenges in healthcare transactions and personalised care. Our focus remains on advancing our genAI capabilities to drive innovation, deliver impactful solutions, and empower businesses globally to achieve seamless operations and value-based care. This funding accelerates our mission to lead the charge in AI-powered healthcare transformation”
Founded in 2020 by Ashish Chaturvedi and later joined by Swadeep Singh as a co-founder, Consint.AI aims to optimise healthcare claims transactions, making them affordable and efficient with cutting-edge platforms like Risk.ai, engineered to optimise insurance transactions and mitigate fraud, and CIPHR.ai which is designed to enhance critical patient management and streamline claims generation. By harnessing advanced genAI solutions, the company helps businesses across emerging markets and the US to drive value-based care, operational efficiency, and sustainable growth.
In the past 12 months, Consint.AI has expanded in India, the middle east, and Africa. The company recently launched CIPHR.ai, an AI-driven platform tailored for hospitals, built upon custom gen AI models for care personalisation in critical patient management. CIPHR.ai provides intelligence at the point of care and generates claims transactions. It is targeted at emerging health markets and the US Accountable Care Organisation (ACO) sector.
In the past two quarters, the company has achieved significant growth, securing Rs 10 plus crore in signed contracts. This includes multiple multi-year agreements with leading insurance providers and hospital systems. Consint.AI plans to continue expanding Risk.ai to drive transactions in the emerging InsurTech markets, with a focus on product enhancements and accelerated sales efforts. Additionally, it aims to strategically penetrate the US market by establishing a strong product-market fit for its CIPHR.ai provider platform, leveraging its generative AI solutions to meet the specific needs of healthcare providers ACOs.
Consint.AI is focused on the $600 billion healthcare transaction market and with a projected 4x YoY business growth, the company is strategically expanding its Risk.ai product across private and public insurance markets in the APAC and MEA regions.
